nearly $30m cash and MC is $39m. How much valuation the market put on all their pipeline and approved drugs?
Lack of confidence and interest, cash burning feeding into their payroll not share holders account.
PXS need to deliver a SOLID trail result that can really draw attention from the big pharmas, the failed NASH-PXS 4728 hurt not only BI, but also many other big pharma's confidence with PXS, and so far not repaired yet.
and again, the shitty 6 cents CR will put another 150m shares ready to dump for quick profit,
Ann: Becoming a substantial holder, page-8
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
